Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07397273 · ClinicalTrials.gov registry record · NA
Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.
A NA study, sponsored by Northern Illinois University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07397273 is a NA study that has not yet begun recruiting, run by Northern Illinois University. The registered enrollment target is 20 participants.
The verdict
NCT07397273, a NA study, has not yet begun recruiting, sponsored by Northern Illinois University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the present study was to examine the effectiveness of acute A-GPC supplementation on upper and lower body muscular strength, endurance, power, and global levels of activation.
Interventions
- DIETARY_SUPPLEMENT Microcrystalline Cellulose
- DIETARY_SUPPLEMENT L-Alpha glycerylphosphorylcholine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-03-16 |
| Est. Completion | 2026-05-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07397273
The ClinicalTrials.gov registry entry for NCT07397273 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northern Illinois University, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Microcrystalline Cellulose is the first listed.
NCT07397273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07397273 about?
NCT07397273 is a clinical study titled "Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.". The purpose of the present study was to examine the effectiveness of acute A-GPC supplementation on upper and lower body muscular strength, endurance, power, and global levels of activation.
What is the current status of trial NCT07397273?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-03-16. Estimated completion is 2026-05-16.
What interventions are being tested in trial NCT07397273?
The interventions under investigation include: Microcrystalline Cellulose (DIETARY_SUPPLEMENT), L-Alpha glycerylphosphorylcholine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07397273?
This trial is sponsored by Northern Illinois University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.